Development of a simple artificial intelligence method to accurately subtype breast cancers based on gene expression barcodes
Year: 2018
Type: dissertation
Abstract: INTRODUCTION: Breast cancer is a highly heterogeneous disease.The complexity of achieving an accurate diagnosis and an effective treatment regimen lies within this heterogeneity.Subtypes of the disease are not simply molecular, i.e. hormone receptor over-expression or absence, but the tumour itself is heterogeneous in terms of tissue of origin, metastases, and histopathological variability.Accurate tumour classification vastly improves treatment decisions, patient outcomes and 5-year survival rates.Gene expression studies aided by transcriptomic technologies such as microarrays and next-generation sequencing (e.g.RNA-Sequencing) have aided oncology researcher and clinician understanding of the complex molecular portraits of malignant breast tumours.Mechanisms governing cancers, which include tumorigenesis, gene fusions, gene over-expression and suppression, cellular process and pathway involvement, have been elucidated through comprehensive analyses of the cancer transcriptome.Over the past 20 years, gene expression signatures, discovered with both microarray and RNA-Seq have reached clinical and commercial application through the development of tests such as Mammaprint®, OncotypeDX®, and FoundationOne® CDx, all which focus on chemotherapy sensitivity, prediction of x 4.3.5.2 Clustering and SVM classification of GTEx-TCGA integrated data…………………………………………………………………………..85 4.3.5.3 Multi-class classification of healthy breast, normal-adjacent-tumour (NAT) and primary tumour tissues ......................................
Author: Fanechka Naomi Esterhuysen
Institution: University of the Western Cape
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2946404171
